Introduction

Organoids are small, three-dimensional structures grown in the laboratory from stem cells that mimic the architecture and function of real human organs to a significant extent. They are often called mini-organs, though they are not complete organs. They are simplified biological models that reproduce important features of tissues such as the intestine, brain, liver, kidney, lung, and tumor microenvironment.

What they are

Organoids are formed when stem cells are provided with the right growth conditions, nutrients, and signaling environment so that they self-organize into structures resembling parts of an organ.

They are usually derived from:

• Embryonic stem cells
• Induced pluripotent stem cells
• Adult stem cells
• Patient-derived cells

Why they are called mini-organs

They are called mini-organs because they can imitate:

• Three-dimensional tissue organization
• Certain cell types found in the original organ
• Some organ-specific functions
• Disease-related behavior

But they are not full organs because they usually lack complete blood vessels, nerves, immune complexity, and full-body integration.

How they are made

The basic process involves:

• Isolating stem cells
• Placing them in a supportive matrix or scaffold
• Providing growth factors and biochemical signals
• Allowing them to self-organize over time

This process helps cells differentiate and arrange themselves into organ-like structures.

Major types of organoids

• Brain organoids
• Intestinal organoids
• Liver organoids
• Kidney organoids
• Lung organoids
• Pancreatic organoids
• Retinal organoids
• Tumor organoids

Uses of organoids

Disease modelling

Organoids help researchers study diseases in a human-relevant setting.

Examples:

• Cancer
• Genetic disorders
• Neurodevelopmental conditions
• Infectious diseases
• Liver and gut disorders

Drug testing

They are used to test how drugs work on human-like tissues before moving into larger trials.

Advantages:

• Better human relevance than many animal models
• Early toxicity detection
• More accurate efficacy screening

Precision medicine

Patient-derived organoids can be made from an individual’s cells to test which treatment may work best for that specific patient.

This is especially useful in:

• Cancer treatment selection
• Rare disease research
• Personalized therapy development

Regenerative medicine research

Organoids are also used in research on tissue repair, transplantation science, and future regenerative therapies.

Importance in modern biomedical science

Organoids are important because they bridge the gap between:

• Simple cell culture models
• Animal testing
• Human clinical response

They offer a more realistic biological environment than flat two-dimensional cell cultures.

Link with Non-Animal Methodologies

Organoids are a major example of Non-Animal Methodologies.

They support the 3Rs principle:

• Replace
• Reduce
• Refine

This means they help reduce dependence on animal testing while producing more human-relevant biological data.

Advantages

• Mimic human organ biology better than many traditional cell cultures
• Useful for studying complex cell interactions
• Can be patient-specific
• Helpful for drug discovery and toxicology
• Support personalized medicine
• Reduce need for animal experimentation

Limitations

• Not complete organs
• Limited blood supply and immune system components
• May not fully replicate whole-body physiology
• Standardization remains difficult
• Expensive and technically demanding
• Long-term maturation can be challenging

Difference between organoids and organ-on-a-chip

Organoids

• Self-organized 3D cell clusters
• Derived from stem cells
• Mimic organ structure and some functions

Organ-on-a-chip

• Engineered microfluidic device
• Simulates organ environment using chips and channels
• Better for studying flow, pressure, and mechanical forces

Both are important Non-Animal Methodologies, but they are not the same.

Significance for India

Organoids are increasingly relevant in India because of the push toward:

• Advanced biopharmaceutical research
• Reduced animal testing
• Precision medicine
• Human-relevant drug safety studies
• Biopharma SHAKTI and related innovation ecosystems